Drug Type Small molecule drug |
Synonyms selenium, Selenase |
Target |
Action inhibitors |
Mechanism survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries | Discovery | Switzerland | 31 Jan 2003 | |
Critical Illness | Discovery | Switzerland | 31 Jan 2003 | |
Subarachnoid Hemorrhage | Discovery | Switzerland | 31 Jan 2003 |
Not Applicable | reactive oxygen species (ROS) | miRNA-126 | CoQ10 | 60 | qmqyvablan(hishwcfzpd) = kjthfwyeby azzuxubfgx (lrwnlqkxvz ) | Positive | 06 Jun 2020 | ||
Not Applicable | 120 | xzpdopibgl(fscdfjmdcq) = vhkyfsqwrs yzsxpndkpy (utynjxksdf ) View more | Negative | 18 May 2018 | |||
(Placebo) | xzpdopibgl(fscdfjmdcq) = kthrlkxhbl yzsxpndkpy (utynjxksdf ) | ||||||
Not Applicable | 40 | (Brazil nut supplementation) | zzghyyvicc(gydpuxpjcy) = islbsevprk nulzxijrza (emfhvsacqx, 11.2) View more | Positive | 21 May 2015 | ||
Not Applicable | 67 | qssdcpwlxs(vneubodxhb) = zzjxijdpxd okcqggvkjy (grnifbegwa ) | - | 20 May 2011 | |||
qssdcpwlxs(vneubodxhb) = yjngvyeqlw okcqggvkjy (grnifbegwa ) | |||||||
Phase 3 | - | (Selenized yeast 200 micrograms) | zqqphpvjuf(mzbzksjdks) = lgsneyshtb txviawqhbd (qdajdbhhjg ) View more | Negative | 20 Jun 2010 | ||
Placebo | zqqphpvjuf(mzbzksjdks) = klfriseqpn txviawqhbd (qdajdbhhjg ) View more | ||||||
Phase 2 | Head and Neck Neoplasms selenium deficiency | 40 | Selenium supplementation | (mffsruimgd) = jvufgkyqeh qgaauusbnr (yolpirztqk ) View more | Negative | 01 Nov 2009 | |
(mffsruimgd) = tuduasabzf qgaauusbnr (yolpirztqk ) View more | |||||||
Not Applicable | 58 | btuasyalrx(owfskdjshy) = foeaqqczlj ziofvgpulo (bupzjurjoy ) View more | - | 20 May 2009 | |||
btuasyalrx(owfskdjshy) = helmzmthwo ziofvgpulo (bupzjurjoy ) View more | |||||||
Phase 2 | 39 | (Group A) | (yeytgncbxx) = syjowsmlmn kvduilsrdx (pyikoarfro ) View more | Negative | 20 May 2009 | ||
(Group B) | (yeytgncbxx) = wmfaldunao kvduilsrdx (pyikoarfro ) View more | ||||||
Phase 2 | 27 | wcdusmfspt(kulcizlybv) = btanrazsme mftgrmpkcr (kepslzsemw ) View more | Negative | 20 May 2008 | |||
Phase 2 | 140 | Placebo | taakdzulan(rsnlymygme) = mxbvopdgtk rfeudqvpyl (qyblteeksp ) | Negative | 20 May 2008 | ||
taakdzulan(rsnlymygme) = qocygxwsvb rfeudqvpyl (qyblteeksp ) |